Buy Daliresp Online in Australia

What is Daliresp (roflumilast)?

Daliresp is a prescription tablet containing roflumilast. In Australia it is used to lower the risk of COPD flare ups in adults who have chronic bronchitis and frequent exacerbations. The usual dose is one 500 microgram tablet each day. It is not a rescue medicine for sudden breathlessness and should be used alongside other COPD treatments as prescribed by your doctor. Your pharmacist can advise on whether it is subsidised under the Pharmaceutical Benefits Scheme (PBS) or paid privately. Take it exactly as prescribed and avoid skipping doses.

How roflumilast works

Roflumilast is a phosphodiesterase-4 inhibitor. It helps reduce inflammation in the airways and may lower the number of COPD flare ups. It does not provide immediate relief from symptoms, and it does not widen airways in the moment. Regular use as part of a broader COPD plan is important for potential benefit. Inform your clinician if you have had mood changes or sleep problems, as these medicines can affect how you feel.

How to take

Take one 500 mcg tablet once daily. You may take it with or without food, but taking it with a meal can help lessen stomach upset. Try to take it at the same time each day to keep a steady level in your body. Do not double the dose to catch up if you miss a day. If you have trouble with side effects, your doctor may adjust your plan or suggest strategies to help you tolerate the medicine.

Who should not take it

Do not use Daliresp if you have severe liver disease or significant liver impairment, unless your doctor tells you otherwise. Tell your pharmacist or doctor about any history of depression, anxiety, sleep problems, or suicidal thoughts, as roflumilast can affect mood in some people. Also discuss other medicines you take, including over‑the‑counter products and herbal supplements, to check for interactions. If you are pregnant or breastfeeding, ask your clinician for advice before starting this medicine.

Possible side effects

Common side effects include headaches, nausea, weight loss, decreased appetite, diarrhea, back pain and trouble sleeping. These typically begin in the first weeks and may improve over time. If side effects are bothersome or persist, contact your doctor or pharmacist. Seek urgent help if you notice signs of an allergic reaction or unusual mood changes, severe abdominal pain, or yellowing of the skin or eyes, which could indicate liver problems or other serious issues.

Drug interactions and Australian care considerations

Roflumilast is broken down by liver enzymes (CYP3A4 and CYP1A2). Strong inhibitors or inducers of these enzymes can change roflumilast levels. For example, certain antifungals and antibiotics may increase side effects, while some medicines can lower its effectiveness. Always tell your doctor about all medicines you take, including herbal products. In Australia, your pharmacist can help with a personalised medication review, discuss costs, and check PBS eligibility if you’re concerned about price. It is also important to continue standard COPD therapies such as inhaled bronchodilators and steroids unless advised otherwise.

What patients in Australia say

Many Australians report that Daliresp can reduce COPD flare ups when used with other treatments, though some notice GI upset or mood changes in the early weeks. People often appreciate having a daily tablet rather than a frequent inhaler regimen, but tolerance varies. Budget considerations are common, and patients frequently ask about PBS support or private pricing. A careful review with a clinician helps balance benefits with any uncomfortable effects.

Storage and handling

Store Daliresp in its original blister or bottle at room temperature, away from moisture and heat. Keep it out of reach of children. Do not use after the expiry date printed on the packaging. If you miss a dose, take it as soon as you remember, unless it is nearly time for your next dose—then skip the missed dose and resume your usual schedule.